ESTUTC-5 New YorkLog in Sign up

ABBV
ABBVIE INC.
stockNYSE

At CloseNov 5, 2026 3:59:55 PM EST

288.24USD-2.235%(-6.59)7,881,434

Pre-marketNov 5, 2026 9:25:30 AM EST

298.88USD+1.374%(+4.05)

After-hoursNov 5, 2026 4:59:30 PM EST

288.25USD+0.003%(+0.01)

276.83Bid308.01Ask31.18Spread

ABBV News

Day breaks

02:45 PM EST3 Dividend Kings to Buy in November and Never Sell ·

The Motley Fool

12:14 PM EST2 Growth Stocks to Buy in November Without Any Hesitation ·

The Motley Fool

12:09 PM ESTAt ASH, drugmakers to showcase early data for three-pronged cancer therapies ·

BioPharma Dive

11:17 AM EST5 High-Yield Dividend Stocks Paying Up to 6% With Payouts Built to Last ·

24/7 Wall St.

07:42 AM ESTWhat Could AbbVie Stock Be Worth In Three Years? ·

Trefis

06:05 AM ESTWhat State Street Health Care SPDR (XLV) Bought: Eli Lilly Leads on Nov. 3 ·

GuruFocus

06:00 AM ESTSector Trends: Technology Leads, Consumer Defensive Sold on Nov. 3 ·

GuruFocus

01:35 AM EST Healthcare Stocks Are on the Mend. Here Are 6 Ways Investors Can Cash In ·

Kiplinger

05:12 PM ESTAbbVie Inc (ABBV) Stock Up 3.1% but GF Value Says Overvalued -- GF Score: 77/100 ·

GuruFocus

01:59 PM ESTNxera Pharma (SOLTF) Secures $1.5B Licensing Deal with AbbVie for IBD Therapy ·

GuruFocus

01:22 PM ESTAbbVie, Nxera ink licensing deal worth up to $1.5B for bowel disease therapy ·

Seeking Alpha

06:53 AM ESTReed Jobs’s Yosemite raises $350 million second fund to make cancer non-lethal ·

Fortune

06:36 AM ESTAbbVie bolsters UK R&D presence, inks $1.38bn IBD deal with Nxera ·

Pharmaceutical Technology

06:06 AM ESTWhat iShares Core High Dividend (HDV) Bought: Exxon Leads on Nov. 2 ·

GuruFocus

06:06 AM ESTCapital Group Cons. Equity (CGCV) Adds Microsoft and Philip Morris on Monday ·

GuruFocus

06:05 AM ESTState Street Health Care SPDR (XLV) Adds Eli Lilly and J&J on Nov. 2 ·

GuruFocus

03:41 AM ESTNxera Pharma Enters into Global License Agreement with AbbVie for NXE0033744, a Novel EP4 Receptor Agonist for Inflammatory Bowel Disease ·

GlobeNewswire Inc.

12:05 AM ESTABBV SWOT Analysis: Key Insights from 10-Q Filing ·

GuruFocus

08:48 PM ESTSLS Stock Snaps 4-Day Slide As Retail Eyes ASH Abstracts — Fresh Filings Reveal Bigger Swiss, Arizona Pension Bets ·

Stocktwits

07:12 PM ESTAbbVie expands Oxford R&D facility as part of £120 million-plus investment ·

Reuters